Loading...
OTC Markets
Totals
Securities
12,222
Dollar Vol
$2.7B
Share Vol
3.3B
Trades
376,791

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

ALPMY
Astellas Pharma, Inc.

Unsponsored ADR (1 ADS : 1 Ordinary)

9.69

-0.08

-0.82%

9.68 / 9.69 (1 x 1)

Real-Time Best Bid & Ask: 05:00pm 07/22/2025
Delayed (15 Min) Trade Data: 03:59pm 07/22/2025

Astellas Pharma, Inc.

2-5-1, Nihonbashi-Honcho

Chuo-Ku

Tokyo 103-8411

Japan

Business Description
Not available
Financial Reporting
Reporting Status
International Reporting: Tokyo Stock Exchange | Prime Market
Audited Financials
Audited
Latest Report
Not Available
CIK
0001446390
Fiscal Year End
12/31
Company Officers & Contacts
Masao Yoshida
CEO, President

Board of Directors

Not available

Other Company Insiders

Not available

Other Company Insiders are all persons or entities beneficially owning 10% or more of any class of the issuer's securities. Together, officers, directors and other company insiders comprise Company Insiders.
Service Providers

Not available

Profile Data
SIC - Industry Classification
Not Available
Incorporation Information
JP, 1923
Employees
13,666 as of 03/30/2008
Shell
No
Products and Services

Not available

Company Facilities

Not available

Company Notes
Formerly=Yamanouchi Pharmaceuticals Co., Ltd. until 4-05
The Pink Limited Market is for broker-dealers to publicly quote securities with limited to no issuer involvement. Pink Limited companies do not certify their compliance with established reporting standards, have limited availability of disclosure or financial information and may not support their U.S. market. These securities are identified with a yield sign to warn investors to proceed with caution.
Limited Information Icon
Pink Limited Information
Securities
Other Astellas Pharma, Inc. Securities
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.